mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.7 |